Advertisement

Topics

Decreased autofluorescence potential outcome measure for Stargardt disease trials

10:30 EDT 19 Jun 2017 | Healio

In patients with Stargardt disease, 50% of eyes without definitely decreased autofluorescence at first visit may develop atrophic lesions of the retinal pigment epithelium in less than 5 years, which could prove to be a clinical outcome measure for treatment trials in the future, according to a study.The retrospective multicenter cohort study included 390 eyes of 217 patients who were age 6 years and older and had Stargardt disease and pathogenic mutations in the ABCA4 gene. All patients underwent fundus autofluorescence imaging for at least two visits with a minimum of 6 months between at least two visits.

Original Article: Decreased autofluorescence potential outcome measure for Stargardt disease trials

NEXT ARTICLE

More From BioPortfolio on "Decreased autofluorescence potential outcome measure for Stargardt disease trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...